| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |